Satellos Bioscience Inc.
MSLE
$10.02
$0.849.15%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.72M | -9.77M | -7.30M | -5.82M | -5.61M |
| Total Depreciation and Amortization | 1.00K | 1.00K | 0.00 | 3.00K | 0.00 |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 950.00K | 892.00K | 777.00K | 889.00K | 446.00K |
| Change in Net Operating Assets | 2.74M | -710.00K | -735.00K | 803.00K | 319.00K |
| Cash from Operations | -8.03M | -9.59M | -7.26M | -4.13M | -4.84M |
| Capital Expenditure | 0.00 | -4.00K | 0.00 | -3.00K | -3.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.34M | -33.33M | -2.56M | -15.33M | 8.48M |
| Cash from Investing | -3.34M | -33.34M | -2.56M | -15.33M | 8.47M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 37.00K | 47.25M | 147.00K | 700.00K | 1.39M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | 4.65M | -- | -- | -- |
| Cash from Financing | 37.00K | 51.90M | 147.00K | 700.00K | 1.39M |
| Foreign Exchange rate Adjustments | 27.00K | -86.00K | 171.00K | -155.00K | 484.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -11.30M | 8.89M | -9.50M | -18.91M | 5.51M |